By Tessa Eskin Microdosing has officially hit the mainstream. The trend spread like wildfire across Silicon Valley, with tech professionals integrating minute doses of psychedelics into their daily biohacking...
By Brian Lissak With selective medical legalization of psychedelics seemingly imminent, countless patients with mental health issues have high hopes for healing. However, results from clinical trials, safety ratings...
By Brian Lissak Ketamine has become a first-line defense against depression. Thanks to its rapid-acting nature and higher efficacy rates when compared to SSRIs, ketamine received FDA approval on March 5, 2019. Hailed by...
Keren Tzarfaty, Ph.D., M.F.T., is the co-founder of the Hakomi Institute of Israel and a trainer for MAPS in Israel (Multidisciplinary Association for Psychedelic Studies). She is a clinical investigator in the MDMA...
By Tessa Eskin Ayahuasca, also known as caapi or yajé, is a psychoactive brew with deep traditional roots in the Amazon Basin of South America. The Quecha term translates to “vine of the soul” or “vine of the dead”...
